Search

everythinglearnresearchcommunity

for

Search:↓

A woman's excessive hair growth was linked to a rare case of high testosterone caused by a prolactin-producing pituitary tumor.

Women with PCOS may be more susceptible to COVID-19 due to hormonal and psychological factors.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Antioxidants can benefit skin health but should be used carefully to avoid negative effects.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Androgenetic alopecia in women may be improved by targeting oxidative stress, inflammation, and fibrosis.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Young and adult hamsters both respond similarly to testosterone and finasteride treatments, but young hamsters aren't good for testing the inhibitory activity of a specific enzyme.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

A woman's sudden hair loss was linked to azathioprine use despite normal enzyme levels, and improved after stopping the drug and starting treatment.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Prostaglandin D2 increases testosterone levels in skin cells through reactive oxygen species, not enzymes, which could lead to new hair loss treatments.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Early detection and biotin treatment improve outcomes for biotinidase deficiency.

Osaterone acetate reduces prostate size and enzyme levels in dogs with benign prostatic hyperplasia.

Superoxide dismutases help balance cell stress and may aid cancer treatment.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Hirsutism treatments can slow new hair growth, but existing hair needs removal, and eflornithine helps reduce hair growth.

Herbal treatments may effectively manage hair disorders with fewer side effects than conventional therapies.

Enzymes involved in Vitamin A metabolism affect hair growth and type in mice.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Nanozymes show promise for effective and safe cancer treatment.

The enzyme is crucial for skin cell development and can be activated without proteolytic activation.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

This enzyme helps metabolize fatty acids and isoleucine, and could be key in treating neurological diseases and certain cancers.